200,000+ products from a single source!
sales@angenechem.com
Home > Other Building Blocks > 26264-03-9
CAS No: 26264-03-9 Catalog No: AG002SIU MDL No:
Title | Journal |
---|---|
A convenient biomimetic synthesis of optically active putative neurotoxic metabolites of MDMA ('ecstasy') from R-(-)- and S-(+)-N-methyl-α-methyldopamine precursors. | Organic & biomolecular chemistry 20120514 |
On-line electrochemistry-bioaffinity screening with parallel HR-LC-MS for the generation and characterization of modified p38α kinase inhibitors. | Analytical and bioanalytical chemistry 20120401 |
Inhibition of 3,4-methylenedioxymethamphetamine metabolism leads to marked decrease in 3,4-dihydroxymethamphetamine formation but no change in serotonin neurotoxicity: implications for mechanisms of neurotoxicity. | Synapse (New York, N.Y.) 20111001 |
Catecholthioether derivatives: preliminary study of in-vitro antimicrobial and antioxidant activities. | Chemical & pharmaceutical bulletin 20110101 |
[Metabolites of ecstasy and cytotoxicity effects]. | Annales pharmaceutiques francaises 20090301 |
Serotonergic neurotoxic thioether metabolites of 3,4-methylenedioxymethamphetamine (MDMA, 'ecstasy'): synthesis, isolation, and characterization of diastereoisomers. | Chemical research in toxicology 20081201 |
Characterization of catechol-thioether-induced apoptosis in human SH-SY5Y neuroblastoma cells. | Journal of neuroscience research 20080301 |
Bacterial plate assays and electrochemical methods: an efficient tandem for evaluating the ability of catechol-thioether metabolites of MDMA ('ecstasy') to induce toxic effects through redox-cycling. | Chemical research in toxicology 20070401 |
5-S-Cysteinyl-dopamine effect on the human dopaminergic neuroblastoma cell line SH-SY5Y. | Neurochemistry international 20060801 |
Biodegradation of a variety of bisphenols under aerobic and anaerobic conditions. | Water science and technology : a journal of the International Association on Water Pollution Research 20060101 |
Thioether metabolites of 3,4-methylenedioxyamphetamine and 3,4-methylenedioxymethamphetamine inhibit human serotonin transporter (hSERT) function and simultaneously stimulate dopamine uptake into hSERT-expressing SK-N-MC cells. | The Journal of pharmacology and experimental therapeutics 20041001 |
© 2019 Angene International Limited. All rights Reserved.